Even though the determination of HR and HER2 status is routinely performed in breast cancer diagnostics, the predictive and prognostic value of a classification based explicitly on HR/HER2 expression has been rarely analyzed and in part only been reported in supplemental data. This evidence concerns the gene ERBB2 and breast carcinoma.